Eton Pharmaceuticals, Inc.
ETON
$17.28
-$0.18-1.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.27% | -602.08% | -308.44% | -345.56% | -2,757.69% |
| Total Depreciation and Amortization | 157.63% | 108.79% | 27.19% | 34.78% | 27.51% |
| Total Amortization of Deferred Charges | 1,283.17% | 1,119.47% | 847.86% | -41.52% | -37.27% |
| Total Other Non-Cash Items | 125.03% | 49.95% | 0.97% | -2.23% | -8.13% |
| Change in Net Operating Assets | 113.17% | 166.93% | -119.78% | 15.27% | -3.04% |
| Cash from Operations | 29,033.33% | -6.08% | -85.78% | -77.11% | -99.37% |
| Capital Expenditure | 14.29% | 14.29% | -- | -16.67% | -16.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -207.23% | -207.23% | -1,188.77% | -- | -32.15% |
| Cash from Investing | -1,335.15% | -1,335.15% | -5,063.10% | -22,041.67% | -32.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 75.00% | 50.00% | 0.00% | -100.00% | -300.00% |
| Issuance of Common Stock | 2,959.01% | 3,374.80% | 2,126.65% | -31.01% | -30.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,771.52% | 2,694.48% | 3,505.75% | -125.71% | -685.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 298.48% | -60.71% | -226.93% | -120.81% | -185.66% |